Kontakt

Dr. Michael Mende
Dr. Michael Mende
Program Coordinator IMPRS-TP | EKF-TP
Telefon: +49 (0) 89-30622-273
August 2018
Mo Di Mi Do Fr Sa So
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Programm MPLS

Max-Planck-Gesundheitsforum

Weitere Seminare

Weitere Ankündigungen zu Seminaren und Veranstaltungen im Raum München finden sich unter folgenden Verlinkungen:

Munich Neuroscience Lecture Series

Munich Neuroscience Calendar

Life Science Campus Seminars

Fort- und Weiterbildung

Seminare

Munich Psychiatry Lecture Series | MPLS

14878 1533129004

Chromatin-directed alternative splicing in brain reward regions

Regulation of gene expression via stably altered chromatin is a compelling area of study for highly heritable neuropsychiatric diseases, such as addiction (Walker, Cates, Heller, & Nestler, 2015). However, due to the promiscuous nature of chromatin-remodeling factors (Kennedy et al., 2013; Maze et al., 2011), previous studies have largely failed to distinguish between the mere presence and the functional relevance of drug-induced histone post-translational modifications (HPTMs). [mehr]

Munich Psychiatry Lecture Series | MPLS

14880 1533549303

Personalized medicine in Depression: hype or hope?

Symptom profiles, etiology and course trajectories of Major Depressive Disorder (MDD) are heterogeneous. This heterogeneity is hampering scientific research and is limiting effectiveness of therapeutic interventions. The goal of precision medicine is to tailor medical treatment to the individual characteristics of each patient. In order to implement precision medicine in depression care, it is essential to better understand what the driving factors are behind MDD’s heterogeneity. However, examining MDD’s heterogeneity is no sinecure, and there are various different ways to start such scientific explorations. One could start with data-driven or hypothesis-driven approaches, one could start with a focus on the heterogeneity at the symptom level, the environment level or the pathophysiology level. Ideally, whatever the starting point is should not matter and results of different starting points should synchronize. Using several different analytical approaches, our research group has illustrated the distinction of immunometabolic depression as a potentially useful subtype of depression. [mehr]

 
Zur Redakteursansicht
loading content